Skip to content
Search

Latest Stories

HayMax balm recognised as 'Best British Allergy Product 2022'

HayMax, maker of the famous organic drug-free allergen barrier balm has been awarded the ‘British Made Award’ for Best British Allergy Product 2022.

The award celebrates businesses that work tirelessly to make their region one of the most diverse and dynamic the UK has to offer.


HayMax MD and creator Max Wiseberg comments: “This award means a great deal to us. We’ve always been proud that our products have been manufactured in the UK. We are passionate about reducing the cost to the environment so being British-made means we keep the miles down and reduce our carbon footprint.”

HayMax balms are manufactured in the UK. It buys local to reduce the cost to the environment, even if it means it costs a bit more. HayMax’s current pots are now made in the UK, which has been great for reducing their carbon footprint. Its tins come from London.

The new pots can be recycled and re-used. The brand has now switched to using sugar cane to make its pots and has also reduced the amount of material used in the pots by just over 54%. And they have switched from the plastic labels to paper labels.

These pots are recyclable with the roadside collection. So now, HayMax is making a positive contribution to climate change, using up CO2 instead of producing it.

HayMax allergen barrier balms are different from most hay fever products, which work by trying to deal with these symptoms. Instead, HayMax seeks to stop the cause of the problem – namely too much pollen in the body – from occurring.

This helps prevent symptoms completely or helps reduce the severity of symptoms by reducing the pollen load. Prevention rather than cure – since there is currently no cure for hay fever.

Independent university studies have shown that HayMax traps significantly more pollen than an uncoated nostril, and traps all types of grass and tree pollen and that HayMax traps over a third of pollen before it enters the body, in addition to dust mite allergens and pet dander. In an independent survey by Allergy UK, the leading national charity providing support, advice and information for those living with allergic disease, 80% of people say HayMax works. And 94% of people find HayMax quick to be effective; 44% said that it worked immediately and a further 35% said that it worked within an hour or two.

HayMax balms are organic, drug-free and non-drowsy which means they’re suitable for children as well as pregnant and breast-feeding mums. They can also be used whilst driving, operating machinery, for exams and sports.

HayMax organic drug-free allergen barrier balms have an rrp of £8.49 per pot and are available from wholesalers to the health store and pharmacy trade, including Hunts Foods, Queenswood, Jumla, CLF, Avvrax, Hampdens, Sundrelle and Sigma, direct on 01525 406600 or www.haymax.biz.

The HayMax range is supported by national PR and advertising campaigns and POS materials, including giant display boxes, CDUs, leaflets, posters and shelf barkers.

More For You

Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less